vimarsana.com
Home
Live Updates
Elafibranor Granted Priority Review for Primary Biliary Chol
Elafibranor Granted Priority Review for Primary Biliary Chol
Elafibranor Granted Priority Review for Primary Biliary Cholangitis
The FDA has accepted for Priority Review the NDA for elafibranor for the second-line treatment of primary biliary cholangitis.
Related Keywords
Christelle Huguet ,
Drug Administration ,
Head Of Research Development ,
Priority Review ,
New Drug Application ,
Itch Numeric Rating Scale ,